Quantitative method for Hex4, lyso-GM1, Fuc-GlcNAc-Asn, and lyso-sulfatide in cerebrospinal fluid
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- JCR PHARMACEUTICALS CO LTD
- Filing Date
- 2024-12-04
- Publication Date
- 2026-06-16
Smart Images

Figure 0007874706000085 
Figure 0007874706000086 
Figure 0007874706000087
Abstract
Claims
1. A method for quantifying lyso-sulfatide contained in cerebrospinal fluid, The steps include adding an internal standard substance to a solution containing cerebrospinal fluid, The steps include: obtaining an eluate by subjecting a solution containing cerebrospinal fluid to which the internal standard substance has been added to liquid chromatography; The step of subjecting the eluate to mass spectrometry, It consists of, A method wherein the internal standard is represented by the following formula [X]. 【Chemistry 10】
2. The method according to claim 1, wherein the liquid chromatography is reversed-phase chromatography.
3. The method according to claim 1 or 2, wherein the lyso-sulfatide is measured in comparison with an internal standard.
4. The method according to any one of claims 1 to 3, wherein the cerebrospinal fluid is obtained from a patient with a disease in which lyso-sulfatide and / or sulfatide accumulates in the body.
5. The method according to claim 4, wherein the disease is metachromatic leukodystrophy.
6. The method according to claim 4 or 5, wherein the patient has received treatment to reduce the amount of lyso-sulfatide and / or sulfatide present in the body.